For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220131:nRSe1883Aa&default-theme=true
RNS Number : 1883A Nuformix PLC 31 January 2022
31 January 2022
Nuformix plc
("Nuformix" or the "the Company")
Director/PDMR Shareholding
Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet
medical needs in fibrosis and oncology via drug repurposing, announces that it
has granted a total of 3,000,000 warrants each to Dr Alastair Riddell, Dr
Julian Gilbert and Maddy Kennedy with an exercise price of 1.45p per share.
- Ends -
Enquiries:
Nuformix plc via Walbrook
Dr Alastair Riddell, Executive Chairman
Allenby Capital Limited +44 (0) 20 3328 5656
Nick Athanas / George Payne (Corporate Finance)
Stefano Aquilino / Matt Butlin (Sales and Corporate Broking)
Walbrook PR nuformix@walbrookpr.com (mailto:nuformix@walbrookpr.com) or +44 (0)20 7933
8780
Anna Dunphy / Phillip Marriage Tel: +44 (0)7876 741 001 / +44 (0)7867 984 082
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Dr Alastair Riddell
2 Reason for the notification
a) Position/status PDMR - Executive Chairman
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Nuformix plc
b) LEI 2138003XG3H3I2J3BJ24
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Warrants to acquire ordinary shares at a price of 1.45p per share.
Identification code
GB00BYW79Y38
b) Nature of the transaction Granting of warrants
c) Price(s) and volume(s)
Price(s) Volume(s)
0 3,000,000
d) Aggregated information Single Transaction
e) Date of the transaction 31 January 2022
f) Place of the transaction Off-market transaction
d)
Aggregated information
Single Transaction
e)
Date of the transaction
31 January 2022
f)
Place of the transaction
Off-market transaction
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Dr Julian Gilbert
2 Reason for the notification
a) Position/status PDMR - Non-executive Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Nuformix plc
b) LEI 2138003XG3H3I2J3BJ24
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Warrants to acquire ordinary shares at a price of 1.45p per share.
Identification code
GB00BYW79Y38
b) Nature of the transaction Issue of warrants
c) Price(s) and volume(s)
Price(s) Volume(s)
0 3,000,000
d) Aggregated information Single Transaction
e) Date of the transaction 31 January 2022
f) Place of the transaction Off-market transaction
d)
Aggregated information
Single Transaction
e)
Date of the transaction
31 January 2022
f)
Place of the transaction
Off-market transaction
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Maddy Kennedy
2 Reason for the notification
a) Position/status PDMR - Non-executive Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Nuformix plc
b) LEI 2138003XG3H3I2J3BJ24
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Warrants to acquire ordinary shares at a price of 1.45p per share.
Identification code
GB00BYW79Y38
b) Nature of the transaction Issue of Warrants
c) Price(s) and volume(s)
Price(s) Volume(s)
0 3,000,000
d) Aggregated information Single Transaction
e) Date of the transaction 31 January 2022
f) Place of the transaction Off-market transaction
d)
Aggregated information
Single Transaction
e)
Date of the transaction
31 January 2022
f)
Place of the transaction
Off-market transaction
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHWPUMUGUPPGCG